• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用对接和FPL模拟快速预测新型冠状病毒主要蛋白酶的潜在抑制剂

Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations.

作者信息

Pham Minh Quan, Vu Khanh B, Han Pham T Ngoc, Thuy Huong Le Thi, Tran Linh Hoang, Tung Nguyen Thanh, Vu Van V, Nguyen Trung Hai, Ngo Son Tung

机构信息

Graduate University of Science and Technology, Vietnam Academy of Science and Technology Hanoi Vietnam.

Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology Hanoi Vietnam.

出版信息

RSC Adv. 2020 Aug 28;10(53):31991-31996. doi: 10.1039/d0ra06212j. eCollection 2020 Aug 26.

DOI:10.1039/d0ra06212j
PMID:35518150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9056572/
Abstract

Originating for the first time in Wuhan, China, the outbreak of SARS-CoV-2 has caused a serious global health issue. An effective treatment for SARS-CoV-2 is still unavailable. Therefore, in this study, we have tried to predict a list of potential inhibitors for SARS-CoV-2 main protease (Mpro) using a combination of molecular docking and fast pulling of ligand (FPL) simulations. The approaches were initially validated over a set of eleven available inhibitors. Both Autodock Vina and FPL calculations produced consistent results with the experiments with correlation coefficients of = 0.72 ± 0.14 and = -0.76 ± 0.10, respectively. The combined approaches were then utilized to predict possible inhibitors that were selected from a ZINC15 sub-database for SARS-CoV-2 Mpro. Twenty compounds were suggested to be able to bind well to SARS-CoV-2 Mpro. Among them, five top-leads are , , , , and . The obtained results could probably lead to enhance the COVID-19 therapy.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)首次在中国武汉爆发,已引发严重的全球健康问题。目前仍没有针对SARS-CoV-2的有效治疗方法。因此,在本研究中,我们尝试结合分子对接和配体快速拉动(FPL)模拟来预测一系列SARS-CoV-2主要蛋白酶(Mpro)的潜在抑制剂。这些方法首先在一组11种可用抑制剂上进行了验证。自动对接Vina和FPL计算与实验结果一致,相关系数分别为 = 0.72 ± 0.14和 = -0.76 ± 0.10。然后,利用这些组合方法从SARS-CoV-2 Mpro的ZINC15子数据库中预测可能的抑制剂。有20种化合物被认为能够与SARS-CoV-2 Mpro良好结合。其中,五个顶级先导物分别是 、 、 、 和 。所得结果可能有助于加强对2019冠状病毒病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/398e76f6c173/d0ra06212j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/d487f95cc95a/d0ra06212j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/81e2dbd65a35/d0ra06212j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/50bd0407cee5/d0ra06212j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/398e76f6c173/d0ra06212j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/d487f95cc95a/d0ra06212j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/81e2dbd65a35/d0ra06212j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/50bd0407cee5/d0ra06212j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0d/9056572/398e76f6c173/d0ra06212j-f4.jpg

相似文献

1
Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations.使用对接和FPL模拟快速预测新型冠状病毒主要蛋白酶的潜在抑制剂
RSC Adv. 2020 Aug 28;10(53):31991-31996. doi: 10.1039/d0ra06212j. eCollection 2020 Aug 26.
2
Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro.热门自由能方法的基准测试揭示了与 SARS-CoV-2 Mpro 结合的抑制剂。
J Chem Inf Model. 2021 May 24;61(5):2302-2312. doi: 10.1021/acs.jcim.1c00159. Epub 2021 Apr 8.
3
Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.计算机筛选 SARS-CoV-2 主蛋白酶潜在抑制剂。
J Chem Inf Model. 2020 Dec 28;60(12):5771-5780. doi: 10.1021/acs.jcim.0c00491. Epub 2020 Jun 28.
4
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations.利用自由能微扰模拟从现有药物中评估新型冠状病毒2型主要蛋白酶的潜在抑制剂。
RSC Adv. 2020 Nov 9;10(66):40284-40290. doi: 10.1039/d0ra07352k. eCollection 2020 Nov 2.
5
Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2.基于已知药物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶潜在抑制剂的计算估计
RSC Adv. 2021 May 12;11(28):17478-17486. doi: 10.1039/d1ra02529e. eCollection 2021 May 6.
6
Some Flavolignans as Potent Sars-Cov-2 Inhibitors Molecular Docking, Molecular Dynamic Simulations and ADME Analysis.一些类黄酮作为有效的 SARS-CoV-2 抑制剂:分子对接、分子动力学模拟和 ADME 分析。
Curr Comput Aided Drug Des. 2022;18(5):337-346. doi: 10.2174/1573409918666220816113516.
7
Potential inhibitors for SARS-CoV-2 Mpro from marine compounds.来自海洋化合物的新型冠状病毒3C样蛋白酶潜在抑制剂。
RSC Adv. 2021 Jun 23;11(36):22206-22213. doi: 10.1039/d1ra03852d. eCollection 2021 Jun 21.
8
SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.SARS-CoV-2 蛋白酶 Mpro 和 PLpro:使用人工神经网络、配体-蛋白对接、分子动力学模拟和 ADMET 计算设计具有高预测效力和低哺乳动物毒性的抑制剂。
Comput Biol Med. 2023 Feb;153:106449. doi: 10.1016/j.compbiomed.2022.106449. Epub 2022 Dec 23.
9
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro.抑制剂与单体和二聚体新冠病毒Mpro的结合。
RSC Adv. 2021 Jan 13;11(5):2926-2934. doi: 10.1039/d0ra09858b. eCollection 2021 Jan 11.
10
Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.基于异吲哚酮的新型SARS-CoV-2主要蛋白酶抑制剂的虚拟高通量筛选、分子对接、密度泛函理论、量子力学/分子力学、分子动力学和分子力学/泊松-玻尔兹曼表面积研究
J Biomol Struct Dyn. 2022 Oct;40(17):7852-7867. doi: 10.1080/07391102.2021.1904003. Epub 2021 Mar 25.

引用本文的文献

1
High-throughput virtual screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease therapy.使用对接和偏向采样方法对亨廷顿舞蹈病治疗中GPR52潜在抑制剂进行高通量虚拟筛选。
Mol Divers. 2024 Oct;28(5):3331-3347. doi: 10.1007/s11030-023-10763-y. Epub 2023 Dec 1.
2
Acetylcholinesterase Inhibitory Activities of Essential Oils from Vietnamese Traditional Medicinal Plants.越南传统药用植物精油的乙酰胆碱酯酶抑制活性。
Molecules. 2022 Oct 20;27(20):7092. doi: 10.3390/molecules27207092.
3
Searching for potential inhibitors of SARS-COV-2 main protease using supervised learning and perturbation calculations.

本文引用的文献

1
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations.利用自由能微扰模拟从现有药物中评估新型冠状病毒2型主要蛋白酶的潜在抑制剂。
RSC Adv. 2020 Nov 9;10(66):40284-40290. doi: 10.1039/d0ra07352k. eCollection 2020 Nov 2.
2
and determination of glutaminyl cyclase inhibitors.以及谷氨酰胺环化酶抑制剂的测定。
RSC Adv. 2019 Sep 19;9(51):29619-29627. doi: 10.1039/c9ra05763c. eCollection 2019 Sep 18.
3
Estimation of the ligand-binding free energy of checkpoint kinase 1 via non-equilibrium MD simulations.
使用监督学习和微扰计算寻找严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的潜在抑制剂。
Chem Phys. 2023 Jan 1;564:111709. doi: 10.1016/j.chemphys.2022.111709. Epub 2022 Sep 26.
4
Anti-multiple myeloma potential of resynthesized belinostat derivatives: an experimental study on cytotoxic activity, drug combination, and docking studies.重新合成的贝利司他衍生物的抗多发性骨髓瘤潜力:细胞毒性活性、药物联合及对接研究的实验性研究
RSC Adv. 2022 Aug 10;12(34):22108-22118. doi: 10.1039/d2ra01969h. eCollection 2022 Aug 4.
5
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations.利用自由能微扰模拟从现有药物中评估新型冠状病毒2型主要蛋白酶的潜在抑制剂。
RSC Adv. 2020 Nov 9;10(66):40284-40290. doi: 10.1039/d0ra07352k. eCollection 2020 Nov 2.
6
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations.利用原子计算和深度学习算法从天然来源中寻找和设计针对新型冠状病毒主蛋白酶(SARS-CoV-2 Mpro)的潜在抑制剂。
RSC Adv. 2021 Nov 29;11(61):38495-38504. doi: 10.1039/d1ra06534c.
7
Potential inhibitors for SARS-CoV-2 Mpro from marine compounds.来自海洋化合物的新型冠状病毒3C样蛋白酶潜在抑制剂。
RSC Adv. 2021 Jun 23;11(36):22206-22213. doi: 10.1039/d1ra03852d. eCollection 2021 Jun 21.
8
Molecular design of anticancer drugs from marine fungi derivatives.基于海洋真菌衍生物的抗癌药物分子设计
RSC Adv. 2021 Jun 4;11(33):20173-20179. doi: 10.1039/d1ra01855h. eCollection 2021 Jun 3.
9
Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2.基于已知药物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶潜在抑制剂的计算估计
RSC Adv. 2021 May 12;11(28):17478-17486. doi: 10.1039/d1ra02529e. eCollection 2021 May 6.
10
Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 M.关于PF-07321332与新型冠状病毒M蛋白结合及共价抑制机制的见解
RSC Adv. 2022 Jan 28;12(6):3729-3737. doi: 10.1039/d1ra08752e. eCollection 2022 Jan 24.
通过非平衡分子动力学模拟估算检查点激酶1的配体结合自由能。
J Mol Graph Model. 2020 Nov;100:107648. doi: 10.1016/j.jmgm.2020.107648. Epub 2020 Jun 26.
4
Repositioning of 8565 Existing Drugs for COVID-19.8565种现有药物重新定位用于治疗新冠肺炎。
J Phys Chem Lett. 2020 Jul 2;11(13):5373-5382. doi: 10.1021/acs.jpclett.0c01579. Epub 2020 Jun 23.
5
Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease - Inhibitor N3 Complex (PDB ID: 6LU7).基于片段分子轨道的 COVID-19 主蛋白酶-抑制剂 N3 复合物(PDB ID:6LU7)相互作用分析。
J Chem Inf Model. 2020 Jul 27;60(7):3593-3602. doi: 10.1021/acs.jcim.0c00283. Epub 2020 Jun 25.
6
Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.计算机筛选 SARS-CoV-2 主蛋白酶潜在抑制剂。
J Chem Inf Model. 2020 Dec 28;60(12):5771-5780. doi: 10.1021/acs.jcim.0c00491. Epub 2020 Jun 28.
7
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.新型冠状病毒主蛋白酶抑制剂卡莫氟的结构基础
Nat Struct Mol Biol. 2020 Jun;27(6):529-532. doi: 10.1038/s41594-020-0440-6. Epub 2020 May 7.
8
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.通过计算药物再利用研究快速鉴定可能用于治疗冠状病毒病 19(COVID-19)的药物。
J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4.
9
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
10
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.SARS-CoV-2 主蛋白酶的晶体结构为设计改良的 α-酮酰胺抑制剂提供了基础。
Science. 2020 Apr 24;368(6489):409-412. doi: 10.1126/science.abb3405. Epub 2020 Mar 20.